Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery Files Patent Infringement Suits Against Ciphergen, Equbits

NEW YORK, June 27 (GenomeWeb News) - Biomarker-discovery firm Health Discovery said today that it has filed patent infringement lawsuits against Ciphergen Biosystems and Equbits in the United States District Court in Marshall, Texas.

 

The lawsuit alleges that Ciphergen and Equbits have infringed three of Health Discovery's US patents covering various aspects of the company's support vector machine technology.

 

In the complaints, Health Discovery seeks "injunctive relief from further infringement, compensatory damages, enhanced damages, reasonable attorney's fees, prejudgment interest, and other associated costs," the company said.

 

Health Discovery uses its support vector machine pattern-recognition technology to discover biomarkers and biological pathways. The company said the technology also has potential applications in markets such as radiology, Internet search and spam, homeland security, financial futures, and other areas where analysis of large volumes of complex data is required.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.